Evaluation of Topiramate Efficacy on Neuropathic Pain in Patients With Diabetic Polyneuropathy
Message:
Article Type:
Research/Original Article (دارای رتبه معتبر)
Abstract:
Polyneuropathy is one of the most common and disabling complications of diabetes. Severe pain is one of the complications of diabetic polyneuropathy .Over the years, many drugs for the treatment of the pain in diabetic neuropathy have been tried. However, no one is completely effective. In a single-blind clinical trial, 200 patients with painful diabetic neuropathy were studied over 12 weeks. In the intervention group, 100 patients were treated with 100 milligrams of Topiramate per day and 100 patients in the control group treated with 90 milligrams of Gabapentin per day. Pain intensity recorded with Visual analogue scale between 0 to 100 millimeter over twelve weeks. Reduction in pain intensity of ≥30 mm was considered as effective response. The purpose of this study was to investigate the effect of Topiramate in the treatment of pain in diabetic polyneuropathy. The mean reduction in pain intensity over twelve weeks in Topiramate groups were 33.83±12.17 and in Gabapentin group were 30.25±15.66. The relative improvement in the Topiramate group was 89.17%, and in the Gabapentin group was 71.25%, respectively. There was a reduction in the mean pain score in both groups, although no statistically significant difference between the two groups was observed. Both of Topiramate and gabapentin were effective on reduction of pain in diabetic polyneuropathy. We can use both of them separately or in combination with each other or other drugs.
Language:
English
Published:
Acta Medica Iranica, Volume:56 Issue: 12, Dec 2018
Pages:
764 to 768
magiran.com/p1936296  
دانلود و مطالعه متن این مقاله با یکی از روشهای زیر امکان پذیر است:
اشتراک شخصی
با عضویت و پرداخت آنلاین حق اشتراک یک‌ساله به مبلغ 990,000ريال می‌توانید 70 عنوان مطلب دانلود کنید!
اشتراک سازمانی
به کتابخانه دانشگاه یا محل کار خود پیشنهاد کنید تا اشتراک سازمانی این پایگاه را برای دسترسی نامحدود همه کاربران به متن مطالب تهیه نمایند!
توجه!
  • حق عضویت دریافتی صرف حمایت از نشریات عضو و نگهداری، تکمیل و توسعه مگیران می‌شود.
  • پرداخت حق اشتراک و دانلود مقالات اجازه بازنشر آن در سایر رسانه‌های چاپی و دیجیتال را به کاربر نمی‌دهد.
دسترسی سراسری کاربران دانشگاه پیام نور!
اعضای هیئت علمی و دانشجویان دانشگاه پیام نور در سراسر کشور، در صورت ثبت نام با ایمیل دانشگاهی، تا پایان فروردین ماه 1403 به مقالات سایت دسترسی خواهند داشت!
In order to view content subscription is required

Personal subscription
Subscribe magiran.com for 50 € euros via PayPal and download 70 articles during a year.
Organization subscription
Please contact us to subscribe your university or library for unlimited access!